Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
Clinical trial NCT03531294 · COMPLETED
Trial details
- NCT number
- NCT03531294
- Sponsor
- Greater Houston Retina Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2021-04-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.